0000000000388500

AUTHOR

Virginia Bellido

showing 2 related works from this author

Time-in-range for monitoring glucose control: Is it time for a change?

2021

The HbA1c value has been the gold standard for evaluating glucose control for decades. However, it has limitations such as the lack of information on glycemic variability or the risk of hypoglycemia. The increasing use of continuous glucose monitoring has provided patients and healthcare professionals with a range of useful metrics for the management of diabetes. Among them, Time in Range (TIR) is a simple and intuitive metric that gives information regarding the quality of glucose control. It is defined as the time spent in an individual's target glucose range. TIR is strongly correlated with HbA1c, and it has been linked to the risk of developing microvascular and macrovascular complicati…

Blood Glucosemedicine.medical_specialtyEndocrinology Diabetes and MetabolismControl (management)030209 endocrinology & metabolismType 2 diabetesHypoglycemia03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal MedicinemedicineRange (statistics)Humans030212 general & internal medicineGlycemicbusiness.industryBlood Glucose Self-MonitoringGeneral MedicineGold standard (test)medicine.diseaseHypoglycemiaDiabetes Mellitus Type 1Diabetes Mellitus Type 2Emergency medicineMetric (unit)businessDiabetes research and clinical practice
researchProduct

Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus

2020

IntroductionCompare cost of the interstitial liquid glucose flash monitoring (FM) system (FreeStyle Libre 2) versus self-monitoring of blood glucose (SMBG) in adults with type 1 diabetes mellitus (T1DM) in Spain.Research design and methodsA model was developed to estimate, with the perspective of the Spanish health system, the annual costs associated with glucose monitoring and hypoglycemic events management in T1DM population, with multiple insulin daily doses (MDI). According to published evidence, rate of severe hypoglycemia (SHE) of 4.90 episodes per patient-year was applied. Reduction of SHE (58.6%) was modeled associated with FM use. Published rates of hospital care (20.2%) and subseq…

Research designAdultBlood Glucosemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismPopulation030209 endocrinology & metabolismHypoglycemiaBedtimeDiseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineDiabetes mellitusMedicine1867HumansHypoglycemic Agents030212 general & internal medicine1506Epidemiology/Health Services ResearcheducationType 1 diabeteseducation.field_of_studybusiness.industryBlood Glucose Self-Monitoringcost(s)nutritional and metabolic diseasesMonitoring systemmedicine.diseaseRC648-665glucose monitoringDiabetes Mellitus Type 1type 1SpainCohortEmergency medicineadult diabetes cost(s) glucose monitoring type 1adult diabetesbusinessBMJ Open Diabetes Research & Care
researchProduct